Therefore, a luciferase screening cell model based on COL1A1 promoter was established earlier by the authors [12], and was successfully applied to the screening and evaluation of anti-hepatic fibrosis drug candidates [13,14,15]. The gene discussed is COL1A1; the disease is Hepatic fibrosis.